scholarly journals Evidence of hot flash–induced awakenings in menopausal women

2020 ◽  
Vol 16 (S2) ◽  
Author(s):  
Jacob Van Doorn ◽  
Alexandra Paget‐Blanc ◽  
Lauren L. Drogos ◽  
Leah H. Rubin ◽  
Pauline M. Maki
Keyword(s):  
2017 ◽  
Vol Volume 12 ◽  
pp. 1993-2001 ◽  
Author(s):  
Yanwei Zheng ◽  
Yibei Zhou ◽  
Jiangshan Hu ◽  
Jieping Zhu ◽  
Qi Hua ◽  
...  

2006 ◽  
Vol 24 (9) ◽  
pp. 1409-1414 ◽  
Author(s):  
Charles L. Loprinzi ◽  
Ralph Levitt ◽  
Debra Barton ◽  
Jeff A. Sloan ◽  
Shaker R. Dakhil ◽  
...  

Purpose Vasomotor hot flashes are a common problem in menopausal women. Given concerns regarding estrogen and/or combined hormonal therapy, other treatment options are desired. Prior trials have confirmed that progestational agents and newer antidepressants effectively reduce hot flashes. This current trial compared a single intramuscular dose of medroxyprogesterone acetate (MPA), depot preparation, versus daily oral venlafaxine as treatment for hot flashes. Methods Women with bothersome hot flashes were entered onto this trial, were randomly assigned to treatment, and then had a baseline week where hot flash scores were recorded without treatment. They were then treated and observed for 6 weeks; daily diaries were used to measure hot flash frequencies and severities. There were 109 patients per each arm randomly assigned to receive MPA 400 mg intramuscularly for a single dose versus venlafaxine 37.5 mg per day for a week, then 75 mg per day. Results During the sixth week after random assignment, hot flash scores were reduced by 55% in the venlafaxine arm versus 79% in the MPA arm (P < .0001). In an intention-to-treat analysis, 46% of venlafaxine patients (50 of 109) compared with 74% of the MPA patients (81 of 109) had a decrease in hot flashes by more than 50% from baseline (P < .0001). Less toxicity was reported in the MPA arm. Conclusion A single MPA dose seems to be well tolerated and more effectively reduces hot flashes than does venlafaxine.


2016 ◽  
Vol 24 (2) ◽  
pp. 258-267
Author(s):  
Julie L. Otte ◽  
Jingwei Wu ◽  
Menggang Yu ◽  
Claire Shaw ◽  
Janet S. Carpenter

Background and Purpose: Sleep hygiene is one factor that contributes to poor sleep in breast cancer survivors but is poorly measured. The purposes of this study were to (a) evaluate the psychometric properties of the Sleep Hygiene Awareness and Practice Scale (SHAPS) and (b) compare SHAPS scores between midlife women with and without breast cancer. Methods: Cross-sectional, descriptive data from a single-blinded, controlled hot flash intervention trial. Results: 194 women (88 breast cancer survivors; 106 menopausal women). Reliability of the three sections of the SHAPS was inadequate with Cronbach’s alphas ranging from 0.23 to 0.67. Sleep hygiene practices were modestly correlated with global sleep quality in both groups. Conclusions: Findings suggest the SHAPS would need to be revised to be a psychometrically sound measure of sleep hygiene awareness and practice.


Maturitas ◽  
2012 ◽  
Vol 71 ◽  
pp. S69
Author(s):  
P. Mostafa Gharabaghi ◽  
S. Hakimi ◽  
S. Mohammad Alizadeh ◽  
A. Delazar

2015 ◽  
Vol 21 ◽  
pp. 293-294
Author(s):  
Mara Carsote ◽  
Cristina Capatina ◽  
Alexandra Mihai ◽  
Andreea Geleriu ◽  
Rodica Petris ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document